Kainos Medicine, Inc. (KOSDAQ:284620)

South Korea · Delayed Price · Currency is KRW

1,087.00

-105.00 (-8.81%)

Last updated: Aug 14, 2025, 9:00 AM KST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Pharmaceuticals, New Technology Research and Development, Etc.	590.37M	Log In	Log In	Log In
Pharmaceuticals, New Technology Research and Development, Etc. Growth	120.85%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
China	575.37M	Log In	Log In	Log In
China Growth	115.24%	Log In	Log In	Log In
South Korea	15.00M	Log In	Log In	Log In
United States	-	Log In	Log In	Log In